Rich S - Search Results

1

Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study.

Emmons-Bell S, Johnson C, Boon-Dooley A, Corris PA, Leary PJ, Rich S, Yacoub M, Roth GA. Emmons-Bell S, et al. Among authors: rich s. Pulm Circ. 2022 Jan 18;12(1):e12020. doi: 10.1002/pul2.12020. eCollection 2022 Jan. Pulm Circ. 2022. PMID: 35506069 Free PMC article.

2

Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension.

Shah SJ, Thenappan T, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Shah SJ, et al. Among authors: rich s. Circulation. 2008 May 13;117(19):2475-83. doi: 10.1161/CIRCULATIONAHA.107.719500. Epub 2008 May 5. Circulation. 2008. PMID: 18458173

3

The WHO classification of pulmonary hypertension: A case-based imaging compendium.

Ryan JJ, Thenappan T, Luo N, Ha T, Patel AR, Rich S, Archer SL. Ryan JJ, et al. Among authors: rich s. Pulm Circ. 2012 Jan-Mar;2(1):107-21. doi: 10.4103/2045-8932.94843. Pulm Circ. 2012. PMID: 22558526 Free PMC article.

4

The pulmonary hypertension academic research consortium.

Rich S. Rich S. Pulm Circ. 2013 Jan;3(1):203-5. doi: 10.4103/2045-8932.109914. Pulm Circ. 2013. PMID: 23662198 Free PMC article. No abstract available.

5

Pulmonary hypertension: the unaddressed global health burden.

Rich S, Haworth SG, Hassoun PM, Yacoub MH. Rich S, et al. Lancet Respir Med. 2018 Aug;6(8):577-579. doi: 10.1016/S2213-2600(18)30268-6. Epub 2018 Jun 29. Lancet Respir Med. 2018. PMID: 30072105 No abstract available.

6

Are anticoagulants still indicated in pulmonary arterial hypertension?

Olschewski H, Rich S. Olschewski H, et al. Among authors: rich s. Pulm Circ. 2018 Oct-Dec;8(4):2045894018807681. doi: 10.1177/2045894018807681. Epub 2018 Oct 4. Pulm Circ. 2018. PMID: 30284508 Free PMC article.

7

Toward a Universal Definition of Etiologies in Heart Failure: Categorizing Causes and Advancing Registry Science.

Agarwal A, Tromp J, Almahmeed W, Angermann C, Chandramouli C, Cho H, Choi DJ, Damasceno A, Filippatos G, Fonarow GC, Harikrishnan S, Lund L, Masoudi F, Mensah GA, Pathan A, Perel P, Pinto F, Ribeiro AL, Rich S, Sakata Y, Sliwa K, Sundstrom J, Wong R, Yancy C, Yiu K, Zhang J, Zhang Y, Lam CSP, Roth GA; Global Heart Failure Roundtable Group. Agarwal A, et al. Among authors: rich s. Circ Heart Fail. 2024 Apr;17(4):e011095. doi: 10.1161/CIRCHEARTFAILURE.123.011095. Epub 2024 Apr 16. Circ Heart Fail. 2024. PMID: 38626067 Review.

8

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Rich S, Kaufmann E, Levy PS. Rich S, et al. N Engl J Med. 1992 Jul 9;327(2):76-81. doi: 10.1056/NEJM199207093270203. N Engl J Med. 1992. PMID: 1603139 Free article. Clinical Trial.

9

Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.

Pietra GG, Edwards WD, Kay JM, Rich S, Kernis J, Schloo B, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Pietra GG, et al. Among authors: rich s. Circulation. 1989 Nov;80(5):1198-206. doi: 10.1161/01.cir.80.5.1198. Circulation. 1989. PMID: 2805258

10

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

McLaughlin VV, Shillington A, Rich S. McLaughlin VV, et al. Among authors: rich s. Circulation. 2002 Sep 17;106(12):1477-82. doi: 10.1161/01.cir.0000029100.82385.58. Circulation. 2002. PMID: 12234951 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,624 results

Search Page

Filters